Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I crossover ventilation study of GRT6005 versus fentanyl in healthy volunteers
NL-OMON32792Phase 1Active, not recruiting
- Sponsor
- Grünenthal GmbH
- Start
- Mar 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of cebranopadol and fentanyl in pain (3 arms), sponsored by Grünenthal GmbH. Primary endpoint: Respiratory function. Started Mar 2010; status: active, not recruiting.
02
Drugs
cebranopadolfentanyl
03
Conditions
pain
Beyond the preview
Go deeper on NL-OMON32792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32792.